2028 Healthcare Healthcare Provider 
Medico Reach
JUNE 16, 2022
Infographic content: The onset of the COVID-19 pandemic has pushed significant growth in the US Healthcare Industry, with 2022 being the year of consumer influence. With higher interoperability levels and significantly better price transparency for medical bills and drugs, the US healthcare industry is dead set on growth.
Nixon Gwilt Law
MAY 26, 2023
As a law firm focused specifically on healthcare innovation, we get really excited about developing areas of the healthcare industry. Providers are already integrating Virtual Reality ( VR ) into patient care in a variety of ways. So, what are the reimbursement options for healthcare VR? Virtual Reality.
PM360
JUNE 24, 2024
In the rapidly evolving global healthcare landscape, the relationship between patients and healthcare professionals (HCPs) remains crucial for effective treatment and care delivery. Another survey found that only 12% of adults felt healthcare was handled ‘extremely’ or ‘very’ well in the U.S., million by 2028.
Contrarian Sales Techniques
FEBRUARY 10, 2023
Non-invasive healthcare products refer to medical devices or technologies that do not require puncturing the skin or entering the body in any way to diagnose, treat, or monitor a health condition. The market for non-invasive healthcare products is expected to grow significantly in the coming years.
InCrowd
AUGUST 11, 2022
with the strongest opinions being on accuracy of the tests and the importance of consulting with a healthcare provider. We asked respondents to elaborate on how someone who is interested in accessing genetic counseling should go about the process of contacting a Genetic Counselor through a healthcare provider.
pharmaphorum
JANUARY 5, 2023
Everything from transitioning to virtual meetings with healthcare providers, to navigating the logistics of supply chain disruptions, has permanently altered pharma operations – many would say for the better. A new operating model for pharma shifted priorities and forced companies to rethink their organisational strategies.
PM360
APRIL 7, 2023
Most immediately, it will add confusion in the healthcare space,” explains Daniel Sontupe, Associate Partner, Managing Director, The Bloc Value Builders. This will create confusion in the marketplace and may possibly lead to delivery of misinformation to healthcare providers (HCPs) regarding a brand’s drug coverage,” Bambalas says.
Expert insights. Personalized for you.
98 
Let's personalize your content